News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
CHASE WILLIAM J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| CHASE WILLIAM J (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 1,673 shares
@ $0
Granted 2,447 options to buy
@ $45.2, valued at
$110.6k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2019 |
4
| CHASE WILLIAM J (EVP, Finance & Administration) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 27,276 shares
@ $79.41, valued at
$2.2M
|
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2018 |
4
| CHASE WILLIAM J (EVP, Finance & Administration) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 60,000 shares
@ $90, valued at
$5.4M
|
|
| 03/02/2018 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 28,407 shares
@ $118.26, valued at
$3.4M
Sold 38,528 shares
@ $119.4444, valued at
$4.6M
Sold 32,400 shares
@ $114.4965, valued at
$3.7M
Exercised 13,400 options to buy
@ $28.3122, valued at
$379.4k
Exercised 19,000 options to buy
@ $24.2082, valued at
$460k
|
|
| 02/16/2018 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 15,945 shares
@ $0
Granted 17,319 shares
@ $0
Granted 14,991 shares
@ $0
Granted 45,840 options to buy
@ $114.36, valued at
$5.2M
|
|
| 05/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2016 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 95,400 options to buy
@ $54.86, valued at
$5.2M
|
|
| 03/03/2015 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 10,299 shares
@ $60.52, valued at
$623.3k
Paid exercise price by delivering 8,192 shares
@ $60.5, valued at
$495.6k
|
|
| 02/23/2015 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 56,040 shares
@ $0
Granted 110,770 options to buy
@ $58.88, valued at
$6.5M
|
|
| 12/22/2014 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 8,495 shares
@ $68, valued at
$577.7k
Exercised 8,495 options to buy
@ $24.0731, valued at
$204.5k
|
|
| 03/04/2014 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 9,873 shares
@ $51.91, valued at
$512.5k
Sold 2,448 shares
@ $50.191, valued at
$122.9k
Sold 1,400 shares
@ $50.194, valued at
$70.3k
Sold 100 shares
@ $51.195, valued at
$5.1k
|
|
| 02/24/2014 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 53,770 shares
@ $0
Granted 92,740 options to buy
@ $51.42, valued at
$4.8M
|
|
| 12/20/2013 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 6,149 shares
@ $54.32, valued at
$334k
Exercised 963 options to buy
@ $28.9667, valued at
$27.9k
Exercised 1,620 options to buy
@ $34.4889, valued at
$55.9k
Exercised 1,591 options to buy
@ $35.2421, valued at
$56.1k
Exercised 3,438 options to buy
@ $35.985, valued at
$123.7k
|
|
| 03/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/19/2013 |
4
| CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 56,700 shares
@ $0
Paid exercise price by delivering 2,912 shares
@ $37.58, valued at
$109.4k
Granted 115,830 options to buy
@ $35.88, valued at
$4.2M
|
|
|
|